---
figid: PMC10303184__pharmaceutics-15-01612-g001
pmcid: PMC10303184
image_filename: PMC10303184__pharmaceutics-15-01612-g001.jpg
figure_link: /pmc/articles/PMC10303184/figure/F1/
number: Figure 1
figure_title: Curcumin modulates the glycolytic metabolic pathway and has the potential
  to modulate de novo serine synthesis pathway.
caption: 'Curcumin modulates the glycolytic metabolic pathway and has the potential
  to modulate de novo serine synthesis pathway. Blue tiny arrows: decrease of transcript/protein/enzyme
  activity. Stars: direct binding of curcumin to the target protein'
article_title: 'Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for
  Metabolic Reprogramming and Prospects for the Future'
citation: Daniel L. Pouliquen, et al. Pharmaceutics. 2023 Jun;15(6).
year: '2023'
pub_date: 2023-6-
epub_date: 2023-5-29
doi: 10.3390/pharmaceutics15061612
journal_title: Pharmaceutics
journa_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords:
- curcuminoids
- curcumin
- cancer
- signaling pathways
- metabolic reprogramming
- chemosensitization
---
